JP3310222B2 - Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe - Google Patents

Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe

Info

Publication number
JP3310222B2
JP3310222B2 JP14883898A JP14883898A JP3310222B2 JP 3310222 B2 JP3310222 B2 JP 3310222B2 JP 14883898 A JP14883898 A JP 14883898A JP 14883898 A JP14883898 A JP 14883898A JP 3310222 B2 JP3310222 B2 JP 3310222B2
Authority
JP
Japan
Prior art keywords
cylinder
sliding valve
support
syringe
diameter portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP14883898A
Other languages
Japanese (ja)
Other versions
JPH119692A (en
Inventor
哲郎 東川
博和 鈴木
Original Assignee
哲郎 東川
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 哲郎 東川 filed Critical 哲郎 東川
Priority to JP14883898A priority Critical patent/JP3310222B2/en
Publication of JPH119692A publication Critical patent/JPH119692A/en
Application granted granted Critical
Publication of JP3310222B2 publication Critical patent/JP3310222B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • A61M2005/3132Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、一体型シリンダの
拡径部において摺動弁との隙間から薬液を導出可能とし
た簡単な構造のキット式の注射器及びそれに用いる注射
器用摺動弁並びに注射器用シリンダの成形方法に関する
ものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a kit-type syringe having a simple structure in which a chemical solution can be led out from a gap between the slide valve and a slide valve in an enlarged portion of an integral cylinder, a slide valve for the syringe used therefor, and a syringe. The present invention relates to a method for forming a cylinder for use .

【0002】[0002]

【従来の技術】以下に本発明を提起するに至るまでの背
景技術の概要を説明する。1969年にL.Ernerot らに
よってアンプルカット時のガラス破片の薬液への混入問
題が指摘されて以来、バイアル製剤のゴム栓に対する注
射針の穿通によるコアリング問題(ゴム片が削り取られ
る現象)、更には製剤調製時の細菌汚染等数々の重大問
題が提起されることとなった。この結果、容器兼用注射
筒、すなわちキット製剤が開発されるに至った。
2. Description of the Related Art An outline of the background art up to the present invention will be described below. In 1969, L. Ernerot et al. Pointed out the problem of glass shards being mixed into the drug solution during ampoule cutting. Since then, coring problems due to penetration of injection needles into rubber stoppers of vial preparations (phenomena of rubber pieces being scraped off), and more. Has raised a number of serious problems, such as bacterial contamination during the preparation of pharmaceuticals. As a result, a container / syringe, that is, a kit preparation has been developed.

【0003】キット製剤は、薬液が予め注射筒(シリン
ダ)に収納されているため、異物混入や細菌汚染を防ぐ
ことができ、更に医療従事者らの製剤調製時の負担を軽
減させることができるといった多くのメリットを持ち、
今後益々大きな発展を遂げることが予想されている。
[0003] In a kit preparation, a drug solution is stored in an injection cylinder (cylinder) in advance, so that contamination of foreign substances and bacterial contamination can be prevented, and the burden on medical staff during preparation of the preparation can be reduced. Has many benefits such as
It is anticipated that further development will be achieved in the future.

【0004】現在、キット製剤の構造上の形式は二つの
タイプに大別されている。一方は従来のクラシカルなシ
リンダに薬液が収納され、外気との遮断は針接続部のキ
ャップのみで行われるものである。他方は、ガラス製の
シリンダ本体にプラスチック製のバレルが嵌合され、薬
液と外気との遮断にフロントストッパ(前方摺動弁)が
介在する仕組みのものである。一般に医薬品の場合、三
年間の長期保存に耐えなければならない規定があり、前
者よりも後者の方がより好ましいことは言うまでもな
い。
[0004] At present, the structural form of the kit preparation is roughly classified into two types. On the other hand, a chemical solution is stored in a conventional classical cylinder, and the outside air is shut off only by a cap at the needle connection portion. The other is a mechanism in which a plastic barrel is fitted to a glass cylinder main body, and a front stopper (front sliding valve) intervenes between the chemical liquid and the outside air. In general, in the case of pharmaceuticals, there are regulations that must withstand long-term storage for three years, and it goes without saying that the latter is more preferable than the former.

【0005】通常、ガラスシリンジの場合、シリンダ内
部に加工を施すことは不可能であり、加工のできるプラ
スチック製バレルと、ガラス製シリンダ本体とを嵌合さ
せるシリンジは開発当時としては止むを得ない選択であ
ったかもしれない。近年、米国FDAはかかるキット製
剤に対し、薬液充填前は勿論のこと、充填後の滅菌を義
務づけることとなった。
[0005] Normally, in the case of a glass syringe, it is impossible to process the inside of the cylinder, and a syringe in which a workable plastic barrel and a glass cylinder body are fitted is unavoidable at the time of development. Might have been a choice. In recent years, the U.S. FDA has mandated such kit preparations to be sterilized after filling, as well as before filling with the drug solution.

【0006】しかしながら、前記バレル式の注射器を用
いた場合には、この後滅菌時に流通水蒸気がバレル内に
浸入するという問題が発生した。そこで、後滅菌時に流
通水蒸気等が浸入することのないキット式注射器が必須
となった。この前提条件としてはフロントストッパを有
したものであることが望ましい。さらに以下の条件を満
足することが必要となった。 1.構造が単純であること。 2.安定感があり、操作が簡単であること。 3.製造コストが低廉であること。 4.産業廃棄物処理が安易であること(可燃性)。
[0006] However, when the barrel-type syringe is used, there arises a problem that the flowing steam enters the barrel during sterilization. Therefore, a kit-type syringe that does not allow inflow of steam or the like during post-sterilization has become essential. As a prerequisite, it is desirable to have a front stopper. Further, the following conditions must be satisfied. 1. The structure is simple. 2. There is a sense of stability and easy operation. 3. Manufacturing cost is low. 4. Easy disposal of industrial waste (flammable).

【0007】以下に上記従来の背景技術を具体的に説明
する。図15は、特公昭62−58745号に記載され
た従来のキット式注射器を示すものである。この注射器
70は、シリンダ82内に予め注射剤76を充填保存
し、注射の際に注射針を取り付けるだけで簡単に注射で
きるものであり、ガラス製で筒状のシリンダ本体71
と、該シリンダ本体71の前端部に嵌合固定された合成
樹脂製のバレル72と、シリンダ本体71内に配置され
た各摺動弁73(フロントストッパゴム)と75(エン
ドストッパゴム,プランジャ)及び両者の間に充填され
た薬液76と、バレル72の先端の注射針接続部78を
覆う合成樹脂製のキャップ83とにより構成される。
Hereinafter, the background art of the related art will be specifically described. FIG. 15 shows a conventional kit type syringe described in Japanese Patent Publication No. 62-58745. This syringe 70 can be easily injected by prefilling and storing an injection 76 in a cylinder 82 and attaching an injection needle at the time of injection, and is made of a cylindrical cylinder body 71 made of glass.
A synthetic resin barrel 72 fitted and fixed to the front end of the cylinder body 71; sliding valves 73 (front stopper rubber) and 75 (end stopper rubber, plunger) arranged in the cylinder body 71; And a chemical liquid 76 filled between them, and a synthetic resin cap 83 covering the injection needle connection portion 78 at the tip of the barrel 72.

【0008】該バレル72の内径はシリンダ本体71の
内径と同一に形成され、バレル72の内壁には、注射針
接続部78の吐出孔80に続く薬液導出用の溝81が形
成されている。そしてプランジャロッド77を押すこと
により、摺動弁73がバレル72内に移動し、薬液76
が溝81から吐出孔80へ導入される。なお、鎖線で示
す摺動弁74は、プランジャロッド77の一回の押し込
み操作で二種類の薬液を分注させる場合のものである。
The inside diameter of the barrel 72 is formed to be the same as the inside diameter of the cylinder body 71, and the inside wall of the barrel 72 is formed with a groove 81 for drawing out a chemical solution that follows the discharge hole 80 of the injection needle connection portion 78. When the plunger rod 77 is pushed, the sliding valve 73 moves into the barrel 72,
Is introduced from the groove 81 into the discharge hole 80. The slide valve 74 indicated by a chain line is for dispensing two types of chemicals by a single pushing operation of the plunger rod 77.

【0009】上記注射器70は医療従事者がキャップ8
3を外して注射針を付け、薬液を充填する手間をかけず
に直ぐに患者に注射することができるものであり、既存
の注射器に較べ、薬液吸引時の注射針の汚染や、薬液充
填時のアンプルカットによるガラス片の混入やバイアル
のゴム栓穿通時のゴム片の混入や細菌の侵入といった不
具合が防止されている。
The above-mentioned syringe 70 is provided with a cap 8 by a medical worker.
3 removes the needle and attaches it, and the patient can be injected immediately without the trouble of filling the medicinal solution. Compared with the existing syringes, contamination of the needle at the time of aspirating the medicinal solution and contamination at the time of filling the medicinal solution can be achieved. Problems such as mixing of glass pieces due to ampoule cutting, mixing of rubber pieces when penetrating the rubber stopper of the vial, and invasion of bacteria are prevented.

【0010】ところが、このキット製剤が薬剤容器であ
ると同時に注射器であるということから、その製造にお
いて滅菌工程が重要なものとなった。具体的には、近年
アメリカFDAが発表したように、薬剤充填前の前滅菌
に加えて、薬剤充填後の後滅菌が要求されるに至った。
前滅菌は、通常製剤メーカーが注射器メーカーから殆ど
組み立て完了したシリンジ(滅菌済)の納入を受け、そ
れを再度製造時に滅菌するものである。一方、薬剤もオ
ートクレーブないしは濾過滅菌等の処理をする。次いで
後滅菌として薬剤充填後に再び100°C、30分ない
しは121°C、20分その他種々の条件で滅菌が行わ
れる。後滅菌処理は100°Cの流通水蒸気を30分な
いしは121°Cの流通水蒸気を20分吹き付けて行わ
れる。例えば注射器内の薬液としてHA(ヒアルロン酸
ナトリウム)のように熱に弱い製剤を用いる場合には1
00°C、30分という条件が設定される。
[0010] However, since this kit preparation is both a drug container and a syringe, a sterilization step has become important in the production thereof. Specifically, as recently announced by the US FDA, in addition to pre-sterilization before drug filling, post-sterilization after drug filling has been required.
In pre-sterilization, a pharmaceutical manufacturer usually receives a syringe (sterilized) that has been almost assembled from a syringe manufacturer and sterilizes it again at the time of manufacture. On the other hand, the drug is also subjected to treatment such as autoclave or filtration sterilization. Next, as post-sterilization, sterilization is performed again at 100 ° C., 30 minutes or 121 ° C., 20 minutes after filling the drug, and various other conditions. The post-sterilization treatment is performed by spraying the flowing steam at 100 ° C. for 30 minutes or the flowing steam at 121 ° C. for 20 minutes. For example, when a heat-sensitive preparation such as HA (sodium hyaluronate) is used as a drug solution in a syringe, 1
The conditions of 00 ° C. and 30 minutes are set.

【0011】しかしながら、上記キット式注射器70に
おいては、後滅菌工程において特にバレル72とシリン
ダ本体71との間の小さな嵌合隙間から図15の矢印イ
の如くバレル72の空室79内に水蒸気や細菌等が入り
込むという重大な問題が生じた。また、その隙間から長
期保存中に菌等が侵入するという懸念もあった。これは
バレル72を機械的な嵌合のみによってシリンダ本体7
1に組み付けるために、微細な隙間の発生が避けられな
いことと、合成樹脂製のバレル72とガラス製のシリン
ダ本体71とでは膨張係数が大きく異なるために、後滅
菌工程で加熱される際にこの隙間が増大して機械的嵌合
を密に保つことが困難となるためである。
However, in the kit-type injector 70 described above, in the post-sterilization step, steam or the like enters into the empty chamber 79 of the barrel 72 as shown by the arrow A in FIG. 15 particularly through a small fitting gap between the barrel 72 and the cylinder body 71. The serious problem that bacteria etc. enter has arisen. There was also a concern that bacteria and the like would enter through the gap during long-term storage. This is because the barrel 72 is attached only by mechanical fitting.
In order to assemble in the first step, since the generation of minute gaps is inevitable and the expansion coefficient of the synthetic resin barrel 72 and the glass cylinder body 71 is significantly different, when heated in the post-sterilization step, This is because this gap increases and it becomes difficult to keep the mechanical fitting dense.

【0012】また、上記キット式注射器70において
は、バレル72とシリンダ本体71とが別体であり、且
つ構造が複雑で、しかもシリンダ本体71が不燃性で産
業廃棄物処理が安易でないという問題があった。
In the kit-type injector 70, the barrel 72 and the cylinder body 71 are separate parts, and
Structure is complicated and the cylinder body 71 is nonflammable.
There was a problem that industrial waste treatment was not easy .

【0013】[0013]

【発明が解決しようとする課題】本発明は、上記した各
点に鑑み、後滅菌工程における水蒸気等の浸入や長期保
存時における菌等の侵入を防止することができるのは勿
論のこと、構造が簡単でしかも産業廃棄物処理が安易な
キット式の注射器及びそれに用いる注射器用摺動弁並び
注射器用シリンダの成形方法を提供することを目的と
する。
SUMMARY OF THE INVENTION It is an object of the present invention has been made in view of the points described above, of course intrusion can be prevented, such as bacteria in infiltration and long-term storage, such as water vapor in the subsequent sterilization process, structure is intended to provide a simple and industrial waste treatment method of molding simplistic <br/> kit expression syringe and syringe sliding valve and syringe cylinder used therefor.

【0014】[0014]

【課題を解決するための手段】上記目的を達成するため
に、本発明は、シリンダの小径なストレート部からシリ
ンダ長手方向に環状の拡径部が一体に形成され、該スト
レート部内に挿着される摺動弁の自由状態における外径
よりも該拡径部の内径が大径に形成され、該拡径部の内
周面と該摺動弁の外周面との間の略環状の隙間から摺動
弁後方の薬液が注射針接続部側に導出される注射器にお
いて、前記拡径部が、前記注射針接続部を有するシリン
ダ底壁からシリンダ長手方向に一体に延長形成され、該
シリンダ底壁又は前記摺動弁の前端面に支持用突起が形
成されて、該支持用突起により該シリンダ底壁と該摺動
弁の前端面との間に薬液導出用の隙間が形成され、ある
いは、該シリンダ底壁又は前記摺動弁の前端面に、前記
注射針接続部の内孔に連通する薬液導出溝が形成され、
該薬液導出用の隙間又は該薬液導出溝が、前記拡径部の
内周面と該摺動弁の外周面との間の略環状の隙間に連通
することで、前記摺動弁後方の薬液が該注射針接続部に
導入されることを特徴とする(請求項1)。前記摺動弁
が、摺動弁本体の径方向に放射状に突出する複数の支持
突部を有し、該支持突部が該摺動弁本体よりも伸縮性に
富み、該支持突部が前記拡径部の内周面に接触し、また
前記ストレート部内において該支持突部が該摺動弁本体
と同一径に縮径可能であり、該拡径部において該複数の
支持突部の間から前記薬液が導出されることことも有効
である(請求項2)。また、注射針接続部を有するシリ
ンダ底壁からシリンダ長手方向に環状の拡径部が一体に
延長形成され、該拡径部からシリンダの小径なストレー
ト部が一体に延長形成され、該ストレート部内に挿着さ
れる摺動弁の自由状態における外径よりも該拡径部の内
径が大径に形成され、該拡径部の内周面と該摺動弁の外
周面との間の略環状の隙間から摺動弁後方の薬液が注射
針接続部側に導出される注射器であって、前記摺動弁
が、摺動弁本体の径方向に放射状に突出する複数の支持
突部を有し、該支持突部が該摺動弁本体よりも伸縮性に
富み、該支持突部が前記拡径部の内周面に接触し、また
前記ストレート部内において該支持突部が該摺動弁本体
と同一径に縮径可能であり、該拡径部において該複数の
支持突部の間から前記薬液が導出されることを特徴とす
る(請求項3)。前記支持突部を含む支持部材が前記摺
動弁本体よりも弾性率の低い材料で形成され、該支持部
材が該摺動弁本体の中央に位置する中心部と、該中心部
から放射状に且つ等配に延びる複数の伸縮部とで構成さ
れ、該伸縮部の先端側に前記支持突部が一体に形成され
たことも有効である(請求項4)。 また、摺動弁本体の
径方向に放射状に突出する複数の支持突部を有し、該支
持突部が該摺動弁本体よりも伸縮性に富み、該支持突部
がシリンダの拡径部の内周面に接触可能で、且つ該拡径
部を除く該シリンダの内径部において該摺動弁本体と同
一径に縮径可能であり、該拡径部において該複数の支持
突部の間から摺動弁後方の薬液を導出可能である注射器
用摺動弁を併せて採用する(請求項)。前記支持突部
を含む支持部材が前記摺動弁本体よりも弾性率の低い材
料で形成され、該支持部材が該摺動弁本体の中央に位置
する中心部と、該中心部から放射状に且つ等配に延びる
複数の伸縮部とで構成され、該伸縮部の先端側に前記支
持突部が一体に形成されたことも有効である(請求項
)。また、外型と内型との間で合成樹脂製のシリンダ
を一体成形する注射器の製造方法において、該外型と該
内型とに環状の大径部が形成され、該内型にテーパ状の
中子が挿入され、該内型の大径部が、外側の円弧面と内
側のテーパガイド面とを有する複数の割り型部と、該中
子と該テーパガイド面とに接して、隣接する各割り型部
の間に進入し、大径部の外周面の一部を構成する円弧面
を有する複数の支持部とで構成され、該中子を挿入する
ことで該割り型部が拡径し、且つ各割り型部の間に支持
部が位置し、その状態でシリンダの拡径部が樹脂成形さ
れ、該中子を抜くことで該割り型部と該支持部とがシリ
ンダ内径以下に縮径して該拡径部から脱抜される注射器
の製造方法を併せて採用する(請求項)。前記シリン
ダの材料としてアモルファスポリオレフィン等を用いる
ことも有効である(請求項)。
SUMMARY OF THE INVENTION In order to achieve the above object, the present invention provides a method for manufacturing a cylinder from a small straight portion of a cylinder.
An annular enlarged diameter portion is formed integrally in the longitudinal direction of the
Outer diameter of the sliding valve inserted in the rate part in the free state
The inner diameter of the enlarged diameter portion is formed larger than that of the enlarged diameter portion.
Sliding through a substantially annular gap between the peripheral surface and the outer peripheral surface of the sliding valve
The medicinal solution behind the valve is drawn out to the syringe needle connection side.
Wherein the enlarged diameter portion has the syringe needle connection portion.
And extend integrally from the bottom wall in the longitudinal direction of the cylinder.
A support projection is formed on the bottom wall of the cylinder or on the front end of the sliding valve.
Formed on the cylinder bottom wall by the supporting projections.
A gap is formed between the valve and the front end face for taking out the chemical solution.
Or, the cylinder bottom wall or the front end face of the sliding valve,
A drug solution outlet groove communicating with the inner hole of the injection needle connection portion is formed,
The chemical solution deriving gap or the chemical solution deriving groove is formed in the enlarged diameter portion.
Communicates with a substantially annular gap between the inner peripheral surface and the outer peripheral surface of the sliding valve
By doing so, the chemical solution behind the slide valve is connected to the injection needle connection part.
It is introduced (claim 1). The slide valve has a plurality of support protrusions radially projecting in the radial direction of the slide valve body, the support protrusions are more elastic than the slide valve body, and the support protrusions are The support projection is in contact with the inner peripheral surface of the enlarged diameter portion, and the diameter of the support projection can be reduced to the same diameter as the sliding valve body in the straight portion. It is also effective that the chemical solution is derived (claim 2). In addition, a series having a needle connection portion is provided.
An annular enlarged diameter section is integrated from the bottom wall of the cylinder in the longitudinal direction of the cylinder.
The cylinder is extended and the small diameter storage
Is extended integrally and inserted into the straight part.
The inner diameter of the enlarged portion is larger than the outer diameter of the sliding valve in a free state.
The diameter is formed to be large, and the inner peripheral surface of the enlarged diameter portion and the outside of the sliding valve are formed.
The chemical solution behind the sliding valve is injected from the substantially annular gap between the peripheral surface
A syringe led out to a needle connection side, wherein the sliding valve
Have multiple supports that protrude radially in the sliding valve body
A projection, and the support projection is more elastic than the sliding valve body.
Abundantly, the support protrusion contacts the inner peripheral surface of the enlarged diameter portion, and
In the straight portion, the support projection is provided on the sliding valve body.
It is possible to reduce the diameter to the same diameter as
The liquid medicine is drawn out from between the support protrusions.
(Claim 3). A support member including the support protrusion is formed of a material having a lower elastic modulus than the sliding valve body, and the supporting member is located at the center of the sliding valve body, and radially from the center. It is also effective that the support protrusion is formed integrally with a plurality of extendable and contractible portions that extend equally, and that the support protrusion is integrally formed on the distal end side of the extendable portion . Further, the sliding valve body has a plurality of support protrusions radially protruding in the radial direction, the support protrusions are more elastic than the slide valve body, and the support protrusions are expanded portions of the cylinder. And the inner diameter of the cylinder excluding the enlarged diameter portion can be reduced in diameter to the same diameter as the sliding valve body. In addition, a sliding valve for a syringe that can draw out the chemical solution behind the sliding valve from the valve is also adopted (claim 5 ). A support member including the support protrusion is formed of a material having a lower elastic modulus than the sliding valve body, and the supporting member is located at the center of the sliding valve body, and radially from the center. It is also effective that the supporting projection is formed integrally with a plurality of extending and contracting portions that extend equally, and that the supporting protrusion is integrally formed on the distal end side of the extending and contracting portion.
6 ). Further, in the method of manufacturing a syringe in which a synthetic resin cylinder is integrally molded between an outer mold and an inner mold, an annular large-diameter portion is formed in the outer mold and the inner mold, and the inner mold has a tapered shape. The inner core is inserted, and the large diameter portion of the inner mold is adjacent to the plurality of split mold portions having an outer arc surface and an inner tapered guide surface, in contact with the core and the tapered guide surface. And a plurality of support portions having an arc surface constituting a part of the outer peripheral surface of the large-diameter portion. The split mold portion is expanded by inserting the core. The support portion is located between the split mold portions, and in this state, the enlarged diameter portion of the cylinder is molded with resin, and by removing the core, the split mold portion and the support portion are smaller than the cylinder inner diameter. The method of manufacturing a syringe which is reduced in diameter and removed from the enlarged diameter portion is also adopted (claim 7 ). It is also effective to use an amorphous polyolefin or the like as the material of the cylinder (Claim 8 ).

【0015】[0015]

【発明の実施の形態】以下に本発明の実施の形態の具体
例を図面を用いて詳細に説明する。図1〜図10は本発
明に係る注射器の一実施例を示すものである。この注射
器85は、図1の如くシリンダ86の先端方において注
射針接続部98を有するシリンダ底壁93に、大径な内
径部87aを有する環状の拡径部87を一体に形成し、
拡径部87からシリンダ86の小径なストレート部88
を一体に延長形成し、拡径部87内の断面円形の空間8
9にストレート部88内の摺動弁90,91を外径側の
略環状の隙間92(図2,図4)を存して収容可能と
し、且つ前記シリンダ底壁93に、摺動弁90に対する
複数の支持用突起94を設けて、拡径部87の内周面と
摺動弁90,91の外周面との間の略環状の隙間92
と、支持用突起94と摺動弁90の前端面とのなす隙間
95(図9)とからシリンダ86内の薬液(薬剤)9
6,97を注射針接続部98の内孔98aに導入可能と
したものである。
Embodiments of the present invention will be described below in detail with reference to the drawings. 1 to 10 show an embodiment of a syringe according to the present invention. As shown in FIG. 1, the syringe 85 has an annular enlarged diameter portion 87 having a large inner diameter portion 87a formed integrally with a cylinder bottom wall 93 having an injection needle connection portion 98 at the distal end of the cylinder 86,
From the enlarged diameter portion 87 to the small diameter straight portion 88 of the cylinder 86
Are integrally extended, and a space 8 having a circular cross section in the enlarged diameter portion 87 is formed.
9, a sliding valve 90, 91 in the straight portion 88 can be accommodated with a substantially annular gap 92 (FIGS. 2 and 4) on the outer diameter side. , A plurality of support projections 94 are provided, and a substantially annular gap 92 between the inner peripheral surface of the enlarged diameter portion 87 and the outer peripheral surfaces of the slide valves 90 and 91 is provided.
And a gap 95 (FIG. 9) formed between the support projection 94 and the front end face of the slide valve 90, from a chemical solution (drug) 9 in the cylinder 86.
6, 97 can be introduced into the inner hole 98a of the injection needle connecting portion 98.

【0016】シリンダ86はガラスでもよいが、アモル
ファスポリオレフィン等の成形性に富み、且つ鏡面状態
を得ることのできる合成樹脂材料を用いるのが最良であ
る。本例において拡径部87の外径はシリンダ86のス
トレート部88の外径よりも大径に形成されているが、
拡径部87の内径部87aのみがストレート部88の内
径よりも大径であればよく、拡径部87の外径とストレ
ート部88の外径とを同一寸法に形成することも可能で
ある。本例において拡径部87の外周面は環状の段部9
9を介してストレート部88の外周面に一体に続いてい
る。拡径部87は後述する成形方法(図12〜図14)
により容易に形成することができる。
Although the cylinder 86 may be made of glass, it is best to use a synthetic resin material such as amorphous polyolefin which has a good moldability and can obtain a mirror-like state. In this example, the outer diameter of the enlarged diameter portion 87 is formed to be larger than the outer diameter of the straight portion 88 of the cylinder 86.
It is sufficient that only the inner diameter portion 87a of the enlarged diameter portion 87 has a larger diameter than the inner diameter of the straight portion 88, and the outer diameter of the enlarged diameter portion 87 and the outer diameter of the straight portion 88 can be formed to have the same size. . In this example, the outer peripheral surface of the enlarged diameter portion 87 is formed in an annular stepped portion 9.
9 and integrally with the outer peripheral surface of the straight portion 88. The enlarged diameter portion 87 is formed by a molding method described later (FIGS. 12 to 14).
Can be formed more easily.

【0017】本例においてシリンダ86のストレート部
88内には二つのゴム製の摺動弁(フロントストッパ9
0とミドルストッパ91)が配置され、直列分注型のキ
ット式注射器85を構成している。図1において前方摺
動弁90は拡径部87のやや後方でストレート部88内
に位置し、中間摺動弁91はストレート部88のほぼ中
央に位置している。前方摺動弁90と中間摺動弁91と
の間に第一の薬液96が充填され、中間摺動弁91と後
方のプランジャ(エンドストッパ)100との間に第二
の薬液97が充填されている。例えば第一の薬液96を
局所麻酔剤、第二の薬液97を変形性膝関節症治療剤で
あるヒアルロン酸ナトリウムとすることで、治療剤投与
時の患者の痛みを軽減させることができる。
In this embodiment, two rubber sliding valves (front stopper 9) are provided in the straight portion 88 of the cylinder 86.
0 and a middle stopper 91) are arranged to constitute a kit dispenser 85 of a series dispensing type. In FIG. 1, the front sliding valve 90 is located slightly behind the enlarged diameter portion 87 in the straight portion 88, and the intermediate sliding valve 91 is located substantially at the center of the straight portion 88. The first chemical liquid 96 is filled between the front slide valve 90 and the intermediate slide valve 91, and the second chemical liquid 97 is filled between the intermediate slide valve 91 and the rear plunger (end stopper) 100. ing. For example, by using the first drug solution 96 as a local anesthetic and the second drug solution 97 as sodium hyaluronate as a therapeutic agent for osteoarthritis of the knee, it is possible to reduce the pain of the patient when administering the therapeutic agent.

【0018】図3〜図5に示す如く、各摺動弁90,9
1は共に二種類の異なるゴム部材(摺動弁本体101と
支持部材102)で構成されており、摺動弁90がシリ
ンダ86のストレート部88から拡径部87に進入した
際に、柔らかく伸び縮みし易い一方のゴム部材(支持部
材)102の一部(伸縮部)103が径方向に突出し
て、シリンダ86の拡径部87内で摺動弁90をがたつ
きなく支え、外径側の隙間92を均一に保つ。
As shown in FIGS. 3 to 5, each sliding valve 90, 9
Numeral 1 is composed of two kinds of different rubber members (sliding valve main body 101 and supporting member 102), and when the sliding valve 90 enters the enlarged diameter portion 87 from the straight portion 88 of the cylinder 86, it expands softly. A part (expandable portion) 103 of one rubber member (support member) 102 that easily shrinks protrudes in the radial direction to support the sliding valve 90 within the enlarged diameter portion 87 of the cylinder 86 without rattling, and Is kept uniform.

【0019】図3において一方のゴム部材(支持部材)
102の方が高い圧縮率でシリンダ86のストレート部
88内に組み込まれており、図4の如く摺動弁90がほ
ぼ解放状態となった時に、一方のゴム部材(支持部材)
102が他方のゴム部材(摺動弁本体)101よりもよ
り多く伸長するのである。なお、前方摺動弁90と中間
摺動弁91とは同一に構成されているので、中間摺動弁
91の断面形状及び作用も第図3、図4と同様である。
In FIG. 3, one rubber member (support member)
102 is incorporated in the straight portion 88 of the cylinder 86 at a higher compression ratio, and when the sliding valve 90 is almost released as shown in FIG. 4, one rubber member (support member)
102 extends more than the other rubber member (sliding valve main body) 101. Since the front sliding valve 90 and the intermediate sliding valve 91 have the same configuration, the cross-sectional shape and operation of the intermediate sliding valve 91 are the same as those in FIGS.

【0020】摺動弁本体101は略短円柱状に形成さ
れ、支持部材102は、摺動弁本体101の中央に位置
した略円柱状の中心部104と、中心部104から径方
向に摺動弁本体101内に放射状に延びる略フィン状の
複数枚の伸縮部(突出部)103とで構成されている。
The sliding valve main body 101 is formed in a substantially short cylindrical shape, and the support member 102 has a substantially cylindrical central portion 104 located at the center of the sliding valve main body 101, and slides radially from the central portion 104. The valve body 101 includes a plurality of substantially fin-shaped extending and contracting portions (projecting portions) 103 extending radially.

【0021】図4の如く、伸縮部103の先端(支持突
部)103aは自由状態において摺動弁本体101の外
周面101aから外側に突出し、シリンダの拡径部87
の内周面(内径部)87aに接触する。支持突部103
aは断面半円形状に形成され、拡径部87の内周面87
aに低い摺動抵抗で接触する。
As shown in FIG. 4, the distal end (supporting projection) 103a of the expansion and contraction portion 103 projects outward from the outer peripheral surface 101a of the sliding valve body 101 in the free state, and the enlarged diameter portion 87 of the cylinder is provided.
Contact with the inner peripheral surface (inner diameter portion) 87a of the second member. Support projection 103
a is formed in a semicircular cross section, and the inner peripheral surface 87 of the enlarged diameter portion 87 is formed.
a with low sliding resistance.

【0022】図1の如く支持部材102の伸縮部103
は摺動弁本体101の軸方向中央部に設けられ、伸縮部
103の軸方向長さが伸縮部103の板厚よりも長く設
定されて、略長方形の板状に形成されている。摺動弁本
体101の軸方向両端部は、シリンダ86のストレート
部88の内周面に摺接する環状リップ部105とリップ
部間の環状溝106(図2)とを有している。支持部材
102の中心部104(図1)は軸方向の一方にボス形
状に延びて、摺動弁本体101の一端に中心部先端面1
04aを露呈している。図5の如く摺動弁本体101の
中央部分は両端側の環状リップ部105の外径よりもや
や小径に形成されている。
As shown in FIG.
Is provided at a central portion in the axial direction of the sliding valve main body 101, and the axial length of the elastic portion 103 is set to be longer than the plate thickness of the elastic portion 103, and is formed in a substantially rectangular plate shape. Both ends in the axial direction of the sliding valve main body 101 have an annular lip portion 105 slidingly contacting the inner peripheral surface of the straight portion 88 of the cylinder 86 and an annular groove 106 between the lip portions (FIG. 2). A central portion 104 (FIG. 1) of the support member 102 extends in a boss shape to one side in the axial direction.
04a is exposed. As shown in FIG. 5, the central portion of the sliding valve main body 101 is formed to have a slightly smaller diameter than the outer diameter of the annular lip portions 105 at both ends.

【0023】摺動弁本体101は、硬く変形が少なく伸
び縮みし難い材料で形成され、支持部材102は柔らか
で変形が大きく、摺動弁本体101と同程度ないしはそ
れ以上に弾性(外部から力を加えられて形や体積に一定
の限界内の変化を生じた物体が、力を取り去ると再び元
の状態に回復する性質)のある伸び縮みし易い材料で形
成される。すなわち、支持部材102は摺動弁本体10
1よりも弾性率の低い(圧縮率の高い)材料で形成され
る。摺動弁本体101と支持部材102とは一体に密着
している。
The sliding valve main body 101 is formed of a material which is hard and hardly deforms and does not easily expand and contract. The supporting member 102 is soft and greatly deformed, and is as elastic as the sliding valve main body 101 or more (force from outside). An object that has undergone a change in shape or volume within certain limits due to the addition of is formed of a material that is easily stretchable and contractable, which is a property that returns to its original state when the force is removed. That is, the support member 102 is
It is formed of a material having a lower elastic modulus (higher compressibility) than 1. The sliding valve main body 101 and the support member 102 are in close contact with each other.

【0024】一例として摺動弁本体101にポリウレタ
ン、支持部材102に合成ゴムを使用することができ
る。参考としてポリウレタンの縦弾性率(弾性体が弾性
の限界内でもつ応力と歪みとの比)は70〜700Kgf/
mm2 程度、合成ゴムの縦弾性率は5〜30Kgf/mm2 程度
である。この数値は材料が等方性を示すことを前提とし
て測定されたものであり、実際に使用される形態や外力
の方向を必ずしも考慮したものではない。弾性率に関し
て言えば、摺動弁本体101は弾性率が高く、支持部材
102は弾性率が低い。なお、支持部材102を例えば
多孔質(孔同士のつながりはあってはならない)等のよ
り一層圧縮性の高い材料で形成することも可能である。
また、同一材質であっても圧縮率(弾性率)の異なるも
のであれば可能である。
As an example, the sliding valve body 101 can be made of polyurethane and the support member 102 can be made of synthetic rubber. For reference, the longitudinal modulus of elasticity (ratio of stress to strain that the elastic body has within the elastic limit) is 70 to 700 kgf /.
mm 2 approximately, longitudinal elastic modulus of the synthetic rubber is about 5~30Kgf / mm 2. This numerical value is measured on the premise that the material exhibits isotropic properties, and does not necessarily take into account the form actually used or the direction of external force. As for the elastic modulus, the sliding valve body 101 has a high elastic modulus, and the support member 102 has a low elastic modulus. Note that the support member 102 may be formed of a material having a higher compressibility, such as a porous material (the connection between the holes is not allowed).
Further, even if the same material is used, any material having a different compression ratio (elastic modulus) can be used.

【0025】この摺動弁90,91は、例えば射出成形
の技術では公知であるインサートモールディングという
工法を用いて、先ず摺動弁本体101をモールド成形
し、次いで摺動弁本体101を別の金型に挿入し、ここ
に支持部材102を射出成形することで形成される。
The slide valves 90 and 91 are formed by first molding the slide valve main body 101 by using, for example, a method called insert molding which is known in the art of injection molding, and then mounting the slide valve main body 101 to another metal. It is formed by inserting it into a mold and injection molding the support member 102 here.

【0026】成形完了時において摺動弁本体101と支
持部材102とは界面部で密着しているが、図3の如く
支持部材102の伸縮部103がシリンダのストレート
部88の内壁面で圧縮される時は、伸縮部103の一部
が摺動弁本体101側の側壁101bに沿って移動して
径方向内側に引っ込む。そして摺動弁本体101の外周
面(環状リップ部105)がストレート部88の内面
(内径部)88aに密着して図1の如く薬液96を密封
させる。前方摺動弁90は拡径部87内の空間89から
薬液96を隔離し、薬液96への細菌等の侵入を防いで
いる。
When the molding is completed, the sliding valve body 101 and the support member 102 are in close contact with each other at the interface, but as shown in FIG. 3, the expansion and contraction portion 103 of the support member 102 is compressed on the inner wall surface of the straight portion 88 of the cylinder. When this occurs, a part of the expansion and contraction portion 103 moves along the side wall 101b on the side of the sliding valve body 101 and retracts radially inward. Then, the outer peripheral surface (annular lip portion 105) of the sliding valve body 101 comes into close contact with the inner surface (inner diameter portion) 88a of the straight portion 88 to seal the chemical liquid 96 as shown in FIG. The front slide valve 90 isolates the drug solution 96 from the space 89 in the enlarged diameter portion 87 and prevents bacteria and the like from entering the drug solution 96.

【0027】そして図4の如くシリンダの拡径部87に
摺動弁90が進入した時点で、伸縮部103がその高い
弾性によって摺動弁本体101よりも径方向外側に突出
し、拡径部87に対して摺動弁90を安定に支持する。
摺動弁本体101もその弾性によって外側に拡径する訳
であるが、拡径部87の内径は摺動弁本体101の自由
状態における外径よりも大きく設定されており、隣接す
る伸縮部103,103の間において、拡径部87と摺
動弁本体101との間に薬液導出用の隙間92が形成さ
れる。
When the sliding valve 90 enters the enlarged diameter portion 87 of the cylinder as shown in FIG. 4, the expansion / contraction portion 103 projects radially outward from the sliding valve main body 101 due to its high elasticity. , The sliding valve 90 is stably supported.
The sliding valve body 101 also expands outward due to its elasticity. However, the inner diameter of the enlarged diameter portion 87 is set to be larger than the outer diameter of the sliding valve body 101 in the free state, and the adjacent expansion and contraction portion 103 is expanded. , 103, a gap 92 is formed between the enlarged diameter portion 87 and the sliding valve main body 101 for drawing out a chemical solution.

【0028】この隙間92は例えば0.1〜0.5mm程
度もあれば十分であり、放射状に延びる伸縮部103の
先端(支持突部)103aは円周上に渡ってこの隙間9
2を一定に保ち、それにより薬液96の流量と流速を一
定にし、プランジャロッド107(図1)の操作力を一
定に安定化させる。該伸縮部103の数は最低三本あれ
ばよく、本例のように六本あれば、拡径部87内で摺動
弁90の姿勢が確実に安定する。図2において第一の薬
液96が前方摺動弁90の外径側の隙間92を通って注
射針接続部98の内孔98aから注射針107′へ吐出
される。
It is sufficient if the gap 92 is, for example, about 0.1 to 0.5 mm, and the tip (supporting projection) 103a of the radially extending and contracting portion 103 extends around the circumference of the gap 9a.
2 is kept constant, whereby the flow rate and the flow rate of the chemical solution 96 are kept constant, and the operating force of the plunger rod 107 (FIG. 1) is kept constant. The number of the expansion and contraction portions 103 only needs to be at least three. If the number is six as in this example, the posture of the sliding valve 90 in the enlarged diameter portion 87 is reliably stabilized. In FIG. 2, the first chemical solution 96 is discharged from the inner hole 98a of the injection needle connecting portion 98 to the injection needle 107 'through the gap 92 on the outer diameter side of the front slide valve 90.

【0029】図6は、拡径部87に続くシリンダ底壁9
3に一体に形成した前記支持用突起94を示す図1のC
−C断面図である。シリンダ底壁93は前方摺動弁90
の前端面に対向する平坦な部位であり、シリンダ底壁9
3に注射針接続部98の内孔98aが開口している。
FIG. 6 shows the cylinder bottom wall 9 following the enlarged diameter portion 87.
3 showing the support projection 94 integrally formed with the support projection 3 in FIG.
It is -C sectional drawing. The cylinder bottom wall 93 has a front sliding valve 90
Is a flat portion facing the front end face of the cylinder bottom wall 9.
3, an inner hole 98a of the injection needle connecting portion 98 is opened.

【0030】支持用突起94は前方摺動弁90の前端に
当接して、前方摺動弁90とシリンダ底壁93との間に
薬液導出用の径方向の隙間95を生じさせるためのもの
であり、注射針接続部98の内孔98aとシリンダの拡
径部87の内壁面とのほぼ中間位置に形成されている。
本例において支持用突起94は四つ等配に設けられ、前
方摺動弁90を安定して支持可能である。支持用突起9
4の数は最低三つ以上必要であり、支持用突起94の高
さは1mm程度あればよい。
The support projection 94 is in contact with the front end of the front slide valve 90 to form a radial gap 95 for drawing out the chemical between the front slide valve 90 and the cylinder bottom wall 93. It is formed at a substantially intermediate position between the inner hole 98a of the injection needle connecting portion 98 and the inner wall surface of the enlarged diameter portion 87 of the cylinder.
In this example, four supporting projections 94 are provided evenly, and the front sliding valve 90 can be stably supported. Supporting projection 9
The number of 4 must be at least three or more, and the height of the supporting projection 94 may be about 1 mm.

【0031】シリンダ86側に支持用突起94を設ける
代わりに、図7の如く前方摺動弁901 の前端面108
または両端面に複数の支持用突起109を設けることも
可能である。また、支持用突起109の代わりに図8の
如く前方摺動弁902 の前端壁110又は両端壁に、注
射針接続部98の内孔98aに連通する放射状の薬液導
出溝111を設けることも可能である。また、拡径部8
7内のシリンダ底壁93に従来同様の放射状の溝(図示
せず)を形成することも可能である。但しこれは溝の形
成にコストをかけてもよい場合の話である。
[0031] Instead of providing the supporting projection 94 on the cylinder 86 side, the front end surface 108 of the front sliding valve 90 1 as shown in FIG. 7
Alternatively, a plurality of support projections 109 can be provided on both end surfaces. Further, the front end wall 110 or end walls of the front sliding valve 90 2 as shown in FIG. 8, instead of the supporting protrusions 109, also be provided a radial chemical derivation groove 111 communicating with the inner hole 98a of the needle-connecting portion 98 It is possible. Also, the enlarged diameter portion 8
A radial groove (not shown) may be formed in the cylinder bottom wall 93 in the same manner as in the prior art. However, this is a case in which the formation of the groove may be costly.

【0032】図9は、図2の状態からさらにプランジャ
ロッド107を押して、第一の薬液96を吐出し終え、
中間摺動弁91を拡径部87内に進入させ、第二の薬液
97の吐出を開始した状態を示すものである。
FIG. 9 shows that the plunger rod 107 is further pushed from the state of FIG.
This shows a state in which the intermediate slide valve 91 has entered the enlarged diameter portion 87 and the discharge of the second chemical liquid 97 has started.

【0033】前述の如く中間摺動弁91は前方摺動弁9
0と同様に摺動弁本体101の内部に支持部材102を
有しており、第二の薬液97は、中間摺動弁91と前方
摺動弁90の各摺動弁本体101とシリンダの拡径部8
7との間の軸方向隙間92をそれぞれ通過して、シリン
ダ底壁93側の隙間95を経て吐出される。
As described above, the intermediate slide valve 91 is connected to the front slide valve 9.
0, a supporting member 102 is provided inside the sliding valve body 101, and the second chemical liquid 97 is supplied to the sliding valve bodies 101 of the intermediate sliding valve 91 and the front sliding valve 90, and the expansion of the cylinder. Diameter 8
The fluid is discharged through the gap 95 on the cylinder bottom wall 93 side, passing through the axial gap 92 between them.

【0034】図10は第二の薬液97を吐出完了した状
態を示すものである。シリンダの拡径部87には二つの
摺動弁90,91が収容され、プランジャ100は中間
摺動弁91に当接して停止する。
FIG. 10 shows a state in which the discharge of the second chemical liquid 97 has been completed. Two sliding valves 90 and 91 are housed in the enlarged diameter portion 87 of the cylinder, and the plunger 100 comes into contact with the intermediate sliding valve 91 and stops.

【0035】上記実施例は複数の摺動弁90,91を用
いた分注型注射器の構造を示すものであるが、本発明に
係る注射器は分注型に限らず、一つの摺動弁(フロント
ストッパ90)を用いたノーマルな一液注入型のキット
式注射器や、図11に示すような用時溶解型のキット式
注射器112にも適用可能である。
Although the above embodiment shows the structure of a dispensing type syringe using a plurality of sliding valves 90 and 91, the syringe according to the present invention is not limited to the dispensing type, but may be a single sliding valve (not shown). The present invention is also applicable to a normal one-liquid injection type kit injector using the front stopper 90) and a dissolution type kit injector 112 as shown in FIG.

【0036】この用時溶解型の注射器112は前例同様
の前方摺動弁90と中間摺動弁91との間に粉末の薬剤
113を入れ、中間摺動弁91とプランジャ100との
間に薬液114を充填したものであり、シリンダ115
はアモルファスポリオレフィン等の合成樹脂を用いて、
シリンダ115の先端方に前記同様の拡径部87を形成
し、シリンダ115のストレート部88の中間部内側
に、薬液114を導入可能なバイパス溝116を形成し
てある。このバイパス溝116については先の特願平7
−516102号で提案済である。このバイパス溝11
6に代えて前記同様の拡径部87をシリンダのストレー
ト部88の中間部に形成することも可能である。
In this syringe 112 of the dissolving type at the time of use, a powder drug 113 is put between the front sliding valve 90 and the intermediate sliding valve 91 as in the previous example, and a chemical solution is put between the intermediate sliding valve 91 and the plunger 100. 114, and a cylinder 115
Is a synthetic resin such as amorphous polyolefin,
An enlarged diameter portion 87 similar to the above is formed at the distal end of the cylinder 115, and a bypass groove 116 into which the chemical 114 can be introduced is formed inside the middle portion of the straight portion 88 of the cylinder 115. The bypass groove 116 is described in Japanese Patent Application No.
-516102. This bypass groove 11
Instead of 6, it is also possible to form an enlarged portion 87 similar to the above in the middle of the straight portion 88 of the cylinder.

【0037】上記各例において基本的には摺動弁90,
91に支持部材102を設けなくとも、シリンダの拡径
部87内に進入した摺動弁90,91の外径側の隙間9
2から薬液96,97を導出させることは可能であり、
この場合でも、摺動弁90,91の自由状態における外
径よりも拡径部87の内径を大きく設定することが必須
要件である。
In each of the above examples, basically, the sliding valve 90,
Even if the supporting member 102 is not provided on the 91, the clearance 9 on the outer diameter side of the sliding valves 90 and 91 that have entered the enlarged diameter portion 87 of the cylinder.
It is possible to derive the chemicals 96 and 97 from 2
Even in this case, it is an essential requirement that the inner diameter of the enlarged diameter portion 87 be set larger than the outer diameter of the sliding valves 90 and 91 in the free state.

【0038】また、図5において摺動弁本体101に支
持突部103aのみを設ける(中心部104等はない)
ことも可能であり、その場合は図5の如く支持突部10
3aを設けた摺動弁本体101の中央部を環状リップ部
105よりも小径にして、支持突部103aの撓みを吸
収させる必要がある。図5の実施例においては、摺動弁
本体101の中央部を環状リップ部105よりも小径に
することで、シリンダ内径部に対する無駄な摺動部分を
なくし、前後の環状リップ部105,105でスムーズ
な摺動を可能としている。
Also, in FIG. 5, only the supporting projection 103a is provided on the sliding valve main body 101 (there is no center portion 104 or the like).
In such a case, the support protrusion 10 can be used as shown in FIG.
It is necessary to make the center of the sliding valve body 101 provided with 3a smaller in diameter than the annular lip 105 so as to absorb the bending of the support projection 103a. In the embodiment of FIG. 5, the central portion of the sliding valve body 101 is made smaller in diameter than the annular lip portion 105, so that unnecessary sliding portions with respect to the cylinder inner diameter portion are eliminated, and the front and rear annular lip portions 105, 105 are used. It enables smooth sliding.

【0039】図12(a)(b)〜図13(a)(b)は、本発明に
係る注射器用シリンダの成形方法として、合成樹脂を材
料としてシリンダを成形する方法の一例を示すものであ
る。この方法は、分割式の外型131と、外型131の
内側に配置される縮径可能な内型132と、内型132
の内部にスライド式に挿入されるテーパ状の中子133
とを用いて、シリンダ86に拡径部87を形成させるも
のである。
FIGS. 12 (a) (b) to 13 (a) (b) show an example of a method for molding a cylinder using a synthetic resin as a method for molding a cylinder for a syringe according to the present invention. is there. The method includes a split outer mold 131, a diameter-reducible inner mold 132 disposed inside the outer mold 131, and an inner mold 132.
Core 133 that is slidably inserted inside
By using these, the cylinder 86 is formed with the enlarged diameter portion 87.

【0040】図12(a) において外型131と内型13
2との間にはシリンダ形状の隙間134が形成され、こ
の隙間134に樹脂材が射出される。外型131と内型
132とには、シリンダ(図1の86)の拡径部(図1
の87)に対応して大径部131a,132aがそれぞ
れ形成されている。内型132は大径部132aにおい
て、図12(b) の如く断面略三角形状ないし略台形状の
支持部135と、支持部135で内側のテーパガイド面
136cを支えられる扇状の割り型部136とを備え
る。支持部135は中子133で支持される。割り型部
136はシリンダの内径部を構成する外側の円弧面13
6aを有し、支持部135は隣り合う割り型部136の
間でシリンダの内径の一部を構成する外側の円弧面13
5aを有する。
In FIG. 12A, the outer die 131 and the inner die 13
A gap 134 having a cylindrical shape is formed between the gap 2 and the gap 2, and the resin material is injected into the gap 134. The outer die 131 and the inner die 132 have an enlarged diameter portion (86 in FIG. 1) of the cylinder (86 in FIG. 1).
87), large-diameter portions 131a and 132a are respectively formed. The inner die 132 has a large-diameter portion 132a, a support portion 135 having a substantially triangular or trapezoidal cross section as shown in FIG. 12B, and a fan-shaped split die portion 136 in which the support portion 135 supports the inner tapered guide surface 136c. And The support 135 is supported by the core 133. The split mold portion 136 is formed on the outer arc surface 13 forming the inner diameter portion of the cylinder.
6a, and the supporting portion 135 is formed between the adjacent split mold portions 136 so as to form a part of the inner diameter of the cylinder.
5a.

【0041】そして図13(a)(b)の如く前記隙間134
にシリンダ形状に樹脂材を充填した後、中子133を抜
き出すことにより、支持部135と割り型部136とが
一体的に縮径し、シリンダ86の拡径部87と内型13
2の大径部132aとの間に隙間137が生じ、拡径部
87の段部99から内型132の段部136bが内側に
逃げる。これにより内型132が抜き出され、外型13
1を分割して樹脂一体型のシリンダ86が完成する。な
お、図12(a) でシリンダ底部の突起94( 図1)の形
成位置を中子133の位置とすることで内型132の縮
径時の干渉が避けられる。
As shown in FIGS. 13A and 13B, the gap 134
After the resin material is filled into the cylinder shape, the core 133 is extracted, so that the diameter of the support portion 135 and the split mold portion 136 is reduced integrally, and the enlarged diameter portion 87 of the cylinder 86 and the inner mold 13 are removed.
A gap 137 is generated between the second large-diameter portion 132a and the step portion 136b of the inner die 132 from the step portion 99 of the large-diameter portion 87. As a result, the inner mold 132 is pulled out, and the outer mold 13 is removed.
1 is divided to complete a resin-integrated cylinder 86. In FIG. 12 (a), by setting the formation position of the protrusion 94 (FIG. 1) at the bottom of the cylinder to the position of the core 133, interference when the inner die 132 is reduced in diameter can be avoided.

【0042】図14(a) 〜(f) はガラスを材料としてシ
リンダを成形する方法を示すものである。先ず、図14
(a) の如く素材のガラス棒122を赤熱させる。次いで
(b) の如く円筒内面の型123に素材122を挿入し、
一方よりパンチ124を挿入する。次いで(c) の如くパ
ンチ124を所定の深さまで挿入して、一定の肉厚を持
った前成形品125を造る。次いで(d) の如く、前成形
された盲管125を型123より外し、製品の金型12
6に装着する。この金型126は拡径部127を有して
いる。次いで(e) の如くブローノズル128を挿入し、
高圧の空気でガラス129を金型126の内面に圧着さ
せる。これにより段部99を有するシリンダの拡径部8
7が形成される。最後に(f) の如く金型126を分割し
て製品129を取り出す。
FIGS. 14A to 14F show a method of forming a cylinder using glass as a material. First, FIG.
The material glass rod 122 is glowed red as shown in FIG. Then
(b) Insert the material 122 into the mold 123 on the inner surface of the cylinder as shown in FIG.
The punch 124 is inserted from one side. Next, a punch 124 is inserted to a predetermined depth as shown in (c) to produce a preformed product 125 having a constant thickness. Next, as shown in (d), the preformed blind tube 125 is removed from the mold 123, and the product mold 12 is removed.
Attach to 6. This mold 126 has an enlarged diameter portion 127. Next, the blow nozzle 128 is inserted as shown in (e),
The glass 129 is pressed against the inner surface of the mold 126 with high-pressure air. Thereby, the enlarged diameter portion 8 of the cylinder having the step portion 99
7 is formed. Finally, the mold 126 is divided and the product 129 is taken out as shown in FIG.

【0043】図14の方法は公知のものであり、注射針
接続部については別途成形する。なお、注射針接続部を
形成する底部130を開口させて、特願平7−5161
02号の図2で提案したゴム製の端子仕切を挿着するこ
とも可能である。
The method shown in FIG. 14 is known, and the injection needle connection portion is formed separately. In addition, the bottom part 130 forming the injection needle connection part is opened, and the Japanese Patent Application No. 7-5161 is disclosed.
It is also possible to insert the rubber terminal partition proposed in FIG. 2 of No. 02.

【0044】[0044]

【発明の効果】以上の如くに、請求項1記載の発明によ
れば、従来の別体のバレルをシリンダ本体に組み付ける
構造に較べて、シリンダの中間部からシリンダの空室内
に流通水蒸気や細菌等が侵入する危険が全くないと共
に、シリンダの構造が簡素化・低 コスト化される。ま
た、シリンダを焼却可能な合成樹脂一体シリンダとした
場合には産業廃棄物処理が容易化する。また、請求項
2,3,5記載の発明によれば、シリンダの拡径部にお
いて摺動弁の複数の支持突部の間から薬液が導出される
から、シリンダの内周面に薬液導出用の溝を形成する必
要がなく、注射器の構造が簡素化され、溝の形成に要す
るコストが削減されるのは勿論のこと、拡径部内におい
て摺動弁が複数の支持突部でがたつきなく安定に支持さ
れ、且つ拡径部と摺動弁本体との間の隙間が円周上で一
定に保たれ、それにより薬液の流量と流速が一定化し、
注射時の操作力が安定する。また、請求項4,6記載の
発明によれば、シリンダのストレート部において支持突
部が伸縮部と一体に径方向内側に縮み、摺動弁本体がス
トレート部の内面に密着して薬液を密封させる。 また、
請求項7記載の発明によれば、シリンダの先端側に環状
の拡径部を容易に形成することができるから、従来の別
体のバレルをシリンダ本体に組み付ける方法に較べて、
シリンダの中間部からシリンダの空室内に流通水蒸気や
細菌等が侵入する危険が全くないと共に、シリンダの構
造が簡素化・低コスト化され、且つガラスを用いない焼
却可能な合成樹脂一体シリンダにより産業廃棄物処理が
容易化する。また、請求項記載の発明によれば、シリ
ンダの成形性が良く、且つ鏡面状態を得ることができ
る。
As described above, according to the first aspect of the present invention, compared with the conventional structure in which a separate barrel is assembled to the cylinder body, the flow of steam and bacteria into the chamber of the cylinder from the middle of the cylinder is reduced. danger at all night both to etc. from entering
In addition, the structure of the cylinder is simplified and the cost is reduced . In addition, when the cylinder is an incinerated synthetic resin cylinder, industrial waste treatment is facilitated. Claims
According to the inventions described in 2, 3, and 5, the chemical liquid is led out from between the plurality of support protrusions of the slide valve at the enlarged diameter portion of the cylinder.
Therefore, there is no need to form a groove for taking out a drug solution on the inner peripheral surface of the cylinder , which simplifies the structure of the syringe and reduces the cost required for forming the groove. The valve is stably supported by multiple support protrusions without rattling
And the gap between the enlarged diameter portion and the sliding valve body is
Is kept constant, so that the flow rate and flow rate of the drug solution are constant,
The operating force during injection is stable. According to the fourth and sixth aspects of the present invention , the support projection is provided at the straight portion of the cylinder.
Part shrinks radially inward with the telescopic part, and the sliding valve
The chemical solution is sealed tightly to the inner surface of the tralate part. Also,
According to the invention described in claim 7 , since the annular enlarged diameter portion can be easily formed on the tip side of the cylinder, compared with the conventional method of assembling a separate barrel to the cylinder body,
There is no danger of water vapor and bacteria entering the cylinder from the middle of the cylinder.
The structure is simplified, the cost is reduced , and the incineration-free synthetic resin cylinder that does not use glass facilitates the treatment of industrial waste. According to the invention of claim 8 , the silicon
Good moldability and a mirror-like surface
You.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明に係る注射器の一実施例を示す縦断面図
である。
FIG. 1 is a longitudinal sectional view showing one embodiment of a syringe according to the present invention.

【図2】同じく第一の薬液を吐出している状態を示す縦
断面図である。
FIG. 2 is a longitudinal sectional view showing a state in which a first chemical solution is discharged.

【図3】図1のA−A断面図である。FIG. 3 is a sectional view taken along line AA of FIG. 1;

【図4】図2のB−B断面図である。FIG. 4 is a sectional view taken along line BB of FIG. 2;

【図5】本発明に係る注射器用摺動弁の一実施例を示す
斜視図である。
FIG. 5 is a perspective view showing one embodiment of a sliding valve for a syringe according to the present invention.

【図6】支持用突起を示す図1のC−C断面図である。FIG. 6 is a sectional view taken along the line CC of FIG.

【図7】前方摺動弁に支持用突起を形成した例を示す平
面図である。
FIG. 7 is a plan view showing an example in which a supporting projection is formed on a front sliding valve.

【図8】前方摺動弁に薬液導出溝を形成した例を示す平
面図である。
FIG. 8 is a plan view showing an example in which a chemical solution outlet groove is formed in a front slide valve.

【図9】注射器の第一の薬液を吐出し終えた状態を示す
縦断面図である。
FIG. 9 is a vertical cross-sectional view showing a state where the first medical solution of the syringe has been discharged.

【図10】同じく第二の薬液を吐出し終えた状態を示す
縦断面図である。
FIG. 10 is a longitudinal sectional view showing a state in which the second chemical has been discharged.

【図11】用時溶解型の注射器に一体型シリンダを適用
した例を示す縦断面図である。
FIG. 11 is a longitudinal sectional view showing an example in which an integrated cylinder is applied to a syringe for dissolving before use.

【図12】本発明に係る注射器用シリンダの成形方法
して合成樹脂材でシリンダを成形する状態を示し、(a)
は縦断面図、(b) は(a) のD1 −D1 断面図である。
FIG. 12 shows a state in which a cylinder is molded from a synthetic resin material as a method of molding a cylinder for a syringe according to the present invention, and (a)
2 is a longitudinal sectional view, and (b) is a sectional view taken along line D 1 -D 1 of (a).

【図13】同じく合成樹脂材でシリンダを一体成形した
状態を示し、(a) は縦断面図、(b) は(a) のD2 −D2
断面図である。
[13] Also shown integrally molded state cylinder of synthetic resin, (a) shows the longitudinal sectional view, (b) the D 2 -D 2 of (a)
It is sectional drawing.

【図14】(a) 〜(f) はガラス材でシリンダを成形する
例を示す縦断面図である。
FIGS. 14 (a) to (f) are longitudinal sectional views showing an example in which a cylinder is formed from a glass material.

【図15】従来の注射器を示す縦断面図である。FIG. 15 is a longitudinal sectional view showing a conventional syringe.

【符号の説明】[Explanation of symbols]

85,112 注射器 86,115 シリンダ 87 拡径部 88 ストレート部 90,91 摺動弁 93 シリンダ底壁 94 支持用突起 95 隙間 96,97 薬液 101 摺動弁本体 102 支持部材 103 伸縮部 103a 支持突部 104 中心部 111 薬液導出溝 131 外型 131a,132a 大径部 132 内型 133 中子 135 支持部 135a,136a 円弧面 136 割り型部 136c テーパガイド面 85, 112 Syringe 86, 115 Cylinder 87 Large diameter portion 88 Straight portion 90, 91 Sliding valve 93 Cylinder bottom wall 94 Supporting projection 95 Clearance 96, 97 Chemical solution 101 Sliding valve main body 102 Supporting member 103 Expandable portion 103a Supporting projection 104 central part 111 chemical solution outlet groove 131 outer die 131a, 132a large diameter part 132 inner die 133 core 135 support part 135a, 136a arc surface 136 split type part 136c taper guide surface

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平5−31191(JP,A) 特開 平8−10325(JP,A) 特開 平8−131544(JP,A) 特開 平7−39582(JP,A) 特開 平2−265568(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61M 5/28 A61M 5/315 ────────────────────────────────────────────────── ─── Continuation of the front page (56) References JP-A-5-31191 (JP, A) JP-A-8-10325 (JP, A) JP-A-8-131544 (JP, A) JP-A-7- 39582 (JP, A) JP-A-2-265568 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61M 5/28 A61M 5/315

Claims (8)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 シリンダの小径なストレート部からシリ
ンダ長手方向に環状の拡径部が一体に形成され、該スト
レート部内に挿着される摺動弁の自由状態における外径
よりも該拡径部の内径が大径に形成され、該拡径部の内
周面と該摺動弁の外周面との間の略環状の隙間から摺動
弁後方の薬液が注射針接続部側に導出される注射器にお
いて、 前記拡径部が、前記注射針接続部を有するシリンダ底壁
からシリンダ長手方向に一体に延長形成され、該シリン
ダ底壁又は前記摺動弁の前端面に支持用突起が形成され
て、該支持用突起により該シリンダ底壁と該摺動弁の前
端面との間に薬液導出用の隙間が形成され、あるいは、
該シリンダ底壁又は前記摺動弁の前端面に、前記注射針
接続部の内孔に連通する薬液導出溝が形成され、該薬液
導出用の隙間又は該薬液導出溝が、前記拡径部の内周面
と該摺動弁の外周面との間の略環状の隙間に連通するこ
とで、前記摺動弁後方の薬液が該注射針接続部に導入さ
れる ことを特徴とする注射器。
1. A small diameter straight section of a cylinder
An annular enlarged diameter portion is formed integrally in the longitudinal direction of the
Outer diameter of the sliding valve inserted in the rate part in the free state
The inner diameter of the enlarged diameter portion is formed larger than that of the enlarged diameter portion.
Sliding through a substantially annular gap between the peripheral surface and the outer peripheral surface of the sliding valve
The medicinal solution behind the valve is drawn out to the syringe needle connection side.
There are, the enlarged diameter portion is the cylinder bottom wall having a needle-connecting portion
From the cylinder in the longitudinal direction of the cylinder.
A support projection is formed on a bottom wall or a front end surface of the slide valve.
The support projections allow the cylinder bottom wall to be in front of the sliding valve.
A gap for chemical solution derivation is formed between the end face and
The injection needle is provided on the cylinder bottom wall or the front end face of the slide valve.
A chemical solution outlet groove communicating with the inner hole of the connection portion is formed, and
The lead-out gap or the drug solution lead-out groove is formed on the inner peripheral surface of the enlarged diameter portion.
And a substantially annular gap between the sliding valve and the outer peripheral surface of the sliding valve.
With this, the chemical solution behind the slide valve is introduced into the injection needle connection portion.
Syringe characterized in that it is.
【請求項2】 前記摺動弁が、摺動弁本体の径方向に放
射状に突出する複数の支持突部を有し、該支持突部が該
摺動弁本体よりも伸縮性に富み、該支持突部が前記拡径
部の内周面に接触し、また前記ストレート部内において
該支持突部が該摺動弁本体と同一径に縮径可能であり、
該拡径部において該複数の支持突部の間から前記薬液が
導出されることを特徴とする請求項1記載の注射器。
2. The sliding valve has a plurality of supporting projections radially projecting in a radial direction of the sliding valve body, and the supporting projections are more stretchable than the sliding valve body. The support protrusion contacts the inner peripheral surface of the enlarged diameter portion, and the support protrusion can be reduced in diameter to the same diameter as the sliding valve body in the straight portion,
2. The syringe according to claim 1, wherein the liquid medicine is led out of the enlarged diameter portion from between the plurality of support protrusions.
【請求項3】 注射針接続部を有するシリンダ底壁から
シリンダ長手方向に環状の拡径部が一体に延長形成さ
れ、該拡径部からシリンダの小径なストレート部が一体
に延長形成され、該ストレート部内に挿着される摺動弁
の自由状態における外径よりも該拡径部の内径が大径に
形成され、該拡径部の内周面と該摺動弁の外周面との間
の略環状の隙間から摺動弁後方の薬液が注射針接続部側
に導出される注射器であって、前記摺動弁が、摺動弁本
体の径方向に放射状に突出する複数の支持突部を有し、
該支持突部が該摺動弁本体よりも伸縮性に富み、該支持
突部が前記拡径部の内周面に接触し、また前記ストレー
ト部内において該支持突部 が該摺動弁本体と同一径に縮
径可能であり、該拡径部において該複数の支持突部の間
から前記薬液が導出されることを特徴とする注射器。
3. A cylinder bottom wall having a needle connection.
An annular enlarged portion is formed integrally with the cylinder in the longitudinal direction.
The small diameter straight part of the cylinder is integrated from the enlarged diameter part.
And a sliding valve that is formed in the straight portion and is inserted into the straight portion.
The inner diameter of the enlarged portion is larger than the outer diameter in the free state of
Formed between the inner peripheral surface of the enlarged diameter portion and the outer peripheral surface of the sliding valve.
The chemical solution behind the slide valve flows from the substantially annular gap
Wherein the sliding valve is a sliding valve main body.
It has a plurality of support protrusions that protrude radially in the radial direction of the body,
The supporting projection is more elastic than the sliding valve body,
The protrusion contacts the inner peripheral surface of the enlarged diameter portion, and the
The support projection is reduced to the same diameter as the sliding valve body in the
Diameter, and between the plurality of support projections at the enlarged diameter portion.
Wherein the medicinal solution is derived from the syringe.
【請求項4】 前記支持突部を含む支持部材が前記摺動
弁本体よりも弾性率の低い材料で形成され、該支持部材
が該摺動弁本体の中央に位置する中心部と、該中心部か
ら放射状に且つ等配に延びる複数の伸縮部とで構成さ
れ、該伸縮部の先端側に前記支持突部が一体に形成され
たことを特徴とする請求項2又は3記載の注射器。
4. A support member including said support projection is provided on said sliding member.
The support member is formed of a material having a lower elastic modulus than the valve body.
Is located at the center of the sliding valve body, and
And a plurality of telescopic parts extending radially and equally
The support protrusion is integrally formed on the distal end side of the expansion and contraction portion.
The syringe according to claim 2 or 3, wherein
【請求項5】 摺動弁本体の径方向に放射状に突出する
複数の支持突部を有し、該支持突部が該摺動弁本体より
も伸縮性に富み、該支持突部がシリンダの拡径部の内周
面に接触可能で、且つ該拡径部を除く該シリンダの内径
部において該摺動弁本体と同一径に縮径可能であり、該
拡径部において該複数の支持突部の間から摺動弁後方の
薬液を導出可能であることを特徴とする注射器用摺動
弁。
5. The sliding valve body radially protrudes in the radial direction.
A plurality of support protrusions, wherein the support protrusions are
Is also elastic, and the supporting projection is the inner periphery of the enlarged diameter portion of the cylinder.
The inner diameter of the cylinder that can contact the surface and excluding the enlarged diameter portion
In the portion, the diameter can be reduced to the same diameter as the sliding valve body,
In the enlarged diameter portion, between the plurality of support projections and the rear of the slide valve.
Sliding for syringes characterized by being able to derive a drug solution
valve.
【請求項6】 前記支持突部を含む支持部材が前記摺動
弁本体よりも弾性率の低い材料で形成され、該支持部材
が該摺動弁本体の中央に位置する中心部と、該中心部か
ら放射状に且つ等配に延びる複数の伸縮部とで構成さ
れ、該伸縮部の先端側に前記支持突部が一体に形成され
たことを特徴とする請求項5記載の注射器用摺動弁。
6. A support member including said support projection is provided on said sliding member.
The support member is formed of a material having a lower elastic modulus than the valve body.
Is located at the center of the sliding valve body, and
And a plurality of telescopic parts extending radially and equally
The support protrusion is integrally formed on the distal end side of the expansion and contraction portion.
The sliding valve for a syringe according to claim 5, wherein
【請求項7】 外型と内型との間で合成樹脂製のシリン
ダを一体成形する注射器用シリンダの成形方法におい
て、該外型と該内型とに環状の大径部が形成され、該内
型にテーパ状の中子が挿入され、該内型の大径部が、外
側の円弧面と内側のテーパガイド面とを有する複数の割
り型部と、該中子と該テーパガイド面とに接して、隣接
する各割り型部の間に進入し、大径部の外周面の一部を
構成する円弧面を有する複数の支持部とで構成され、該
中子を挿入することで該割り型部が拡径し、且つ各割り
型部の間に支持部が位置し、その状態でシリンダの拡径
部が樹脂成形され、該中子を抜くことで該割り型部と該
支持部とがシリンダ内径以下に縮径して該拡径部から脱
抜されることを特徴とする注射器用シリンダの成形方
法。
7. A synthetic resin syringe between an outer mold and an inner mold.
Injection cylinder molding method
Thus, an annular large diameter portion is formed in the outer mold and the inner mold,
A tapered core is inserted into the mold, and the large diameter portion of the inner mold is
A plurality of splits having an arcuate surface on the side and an inner tapered guide surface.
Contacting the core and the tapered guide surface, and
Into each split mold part, and remove a part of the outer peripheral surface of the large diameter part.
And a plurality of supporting portions having an arc surface to be constituted.
By inserting the core, the split mold part expands its diameter and
The support part is located between the mold parts, and in that state the cylinder is expanded.
The part is molded with resin, and the core is pulled out so that the split mold part and the
The support part is reduced in diameter to the cylinder inner diameter or less and comes off from the enlarged part.
Molding method for syringe cylinder characterized by being pulled out
Law.
【請求項8】 前記シリンダの材料としてアモルファス
ポリオレフィン等を用いることを特徴とする請求項7記
載の注射器用シリンダの成形方法。
8. An amorphous material as a material of the cylinder.
8. The method according to claim 7, wherein a polyolefin or the like is used.
Method for molding the cylinder for syringe described above.
JP14883898A 1998-05-29 1998-05-29 Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe Expired - Fee Related JP3310222B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14883898A JP3310222B2 (en) 1998-05-29 1998-05-29 Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14883898A JP3310222B2 (en) 1998-05-29 1998-05-29 Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP9508293A Division JP2832086B2 (en) 1995-08-09 1995-12-27 How to seal a syringe

Publications (2)

Publication Number Publication Date
JPH119692A JPH119692A (en) 1999-01-19
JP3310222B2 true JP3310222B2 (en) 2002-08-05

Family

ID=15461874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14883898A Expired - Fee Related JP3310222B2 (en) 1998-05-29 1998-05-29 Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe

Country Status (1)

Country Link
JP (1) JP3310222B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770052B2 (en) * 2000-10-10 2004-08-03 Meridian Medical Technologies, Inc. Wet/dry automatic injector assembly
JP4641819B2 (en) * 2004-05-06 2011-03-02 一般財団法人化学及血清療法研究所 Prefilled syringe
JP4794214B2 (en) * 2005-05-25 2011-10-19 富士フイルム株式会社 High frequency treatment tool
JP4692166B2 (en) * 2005-09-05 2011-06-01 富士フイルム株式会社 High frequency treatment tool
JP4692141B2 (en) * 2005-08-12 2011-06-01 富士フイルム株式会社 High frequency treatment tool
EP3197525B1 (en) 2015-01-28 2018-09-26 Cube Pharmaceuticals N.Kalofolias&Co. OE Devices and methods for establishing communication between chambers in a multi-chambered vessel

Also Published As

Publication number Publication date
JPH119692A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
JP2656665B2 (en) Syringe
WO1997005916A1 (en) Syringe, sealing construction and method therefor, and slide valve for syringe
US5782803A (en) Low dead space, interchangeable needle syringe
US7789862B2 (en) Multi-chamber, sequentially dispensing syringe
US7438552B2 (en) Dispenser for medicaments and method and apparatus for making same
CN101808686B (en) Syringe with disabling mechanism
AU2010202200B2 (en) Single use syringe having safety shield
US5064419A (en) Disposable hypodermic syringe
EP0826385B1 (en) Syringe assembly
US6010486A (en) Retracting needle syringe
CN102341139B (en) Cap lock
US4990141A (en) Single-use syringe
US3527215A (en) Syringe construction having internal bladder
CN105939742A (en) Cartridge and needle assembly in combination
WO2009108847A1 (en) Syringe with two piece plunger rod
KR20160019416A (en) Piston for use a syringe with specific dimensional ratio of a sealing structure
JP2002515268A (en) Syringe assembly
CN104368068A (en) Syringe assembly with inverse delivery
JP3310222B2 (en) Method of forming a syringe, a slide valve for the syringe, and a cylinder for the syringe
CN112638452A (en) Needle hub and syringe device
US4291695A (en) Disposable injection syringe
JP2008099728A (en) Syringe serving also as container
KR20010075164A (en) Drug syringe
JP3065814B2 (en) Chemical filling syringe
JP2004188047A (en) Syringe

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20020409

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees